Contributor: CFturbo, Inc.
Today, CFturbo, Inc., a software company specializing in turbomachinery design software and consulting, announced the new release of their upgraded software, CFturbo 2020.R1. From now on, providing two major software releases each year, CFturbo is continually enhancing its design capabilities. The new release contains many new and upgraded features based on customer feedback and the continuously evolving turbomachinery market. Customers can expect an affordable, accurate, reliable, robust, and user-friendly solution for conceptual turbomachinery design, simulation, and optimization of pumps, blowers and fans, compressors, and turbines. Unlike any other Turbomachinery design software on the market, CFturbo can be uniquely combined with different CAE-codes of third party vendors like ANSYS, NUMECA, SIEMENS PLM, and SIMERICS, or open-source simulation software.
Among the significant new features in CFturbo 2020.R1 are an inverse blade design method based on blade loading, a flexible blade angle distribution and the explicit rake angle definition, the enhanced design of multistage machines, significantly streamlined integration of CFturbo into ANSYS Workbench, and the extension of design parameters for volute optimizations.
“This CFturbo release can be considered as the next big step fulfilling our vision of automated Turbomachinery design exploration. We will enable all kinds of engineers – not only rotating machinery experts – to create efficient Turbomachinery components,” says Mr. Ralph Peter Mueller, President of CFturbo, Inc. “An intuitive, powerful, seamlessly interoperable software platform is the crucial factor in reaching that goal.”
About CFturbo, Inc.: CFturbo is headquartered in Dresden, Germany, with another office in Brooklyn, New York. Founded in 2008, CFturbo is an industry leader in turbomachinery design software. CFturbo services customers spanning a wide variety of industries including aerospace & defense, automotive, energy, oil & gas, HVAC, marine, process industry, appliances and medtech.